Alector to Participate in Upcoming Healthcare Conferences
Alector (NASDAQ: ALEC), a late-stage clinical biotechnology company specializing in neurodegeneration therapies, has announced its participation in three upcoming healthcare investor conferences in September 2025.
The company will present at the Cantor Global Healthcare Conference on September 4 at 3:55 p.m. ET, the Morgan Stanley Global Healthcare Conference on September 8 at 10:00 a.m. ET, and the H.C. Wainwright Global Investment Conference on September 9 at 1:30 p.m. ET. All presentations will be available via webcast on Alector's investor relations website, with replays accessible for 90 days.
Alector (NASDAQ: ALEC), azienda biotecnologica in fase avanzata specializzata in terapie per le neurodegenerazioni, ha comunicato la sua partecipazione a tre conferenze per investitori del settore sanitario previste per settembre 2025.
L’azienda terrà una presentazione al Cantor Global Healthcare Conference il 4 settembre alle 15:55 ET, al Morgan Stanley Global Healthcare Conference l’8 settembre alle 10:00 ET e all’H.C. Wainwright Global Investment Conference il 9 settembre alle 13:30 ET. Tutti gli interventi saranno trasmessi via webcast sul sito dedicato agli investitori di Alector e le registrazioni saranno disponibili per 90 giorni.
Alector (NASDAQ: ALEC), una compañía biotecnológica en etapa avanzada especializada en terapias para la neurodegeneración, ha anunciado su participación en tres próximas conferencias para inversores del sector sanitario en septiembre de 2025.
La empresa presentará en el Cantor Global Healthcare Conference el 4 de septiembre a las 3:55 p.m. ET, en el Morgan Stanley Global Healthcare Conference el 8 de septiembre a las 10:00 a.m. ET y en el H.C. Wainwright Global Investment Conference el 9 de septiembre a la 1:30 p.m. ET. Todas las presentaciones se emitirán por webcast en la web de relaciones con inversores de Alector y las reproducciones estarán disponibles durante 90 días.
Alector (NASDAQ: ALEC), 신경퇴행성 질환 치료제를 전문으로 하는 후기 임상 단계 생명공학 회사가 2025년 9월 개최되는 세 차례의 헬스케어 투자자 콘퍼런스에 참가한다고 발표했습니다.
회사는 Cantor Global Healthcare Conference에 9월 4일 오후 3시 55분(ET)에, Morgan Stanley Global Healthcare Conference에 9월 8일 오전 10시(ET)에, H.C. Wainwright Global Investment Conference에 9월 9일 오후 1시 30분(ET)에 발표를 진행합니다. 모든 발표는 Alector의 투자자 관계 웹사이트를 통해 웨비캐스트로 제공되며, 재생은 90일간 이용할 수 있습니다.
Alector (NASDAQ: ALEC), une société biotechnologique en phase avancée spécialisée dans les thérapies contre la neurodégénérescence, a annoncé sa participation à trois conférences destinées aux investisseurs dans le secteur de la santé en septembre 2025.
La société présentera au Cantor Global Healthcare Conference le 4 septembre à 15h55 ET, au Morgan Stanley Global Healthcare Conference le 8 septembre à 10h00 ET et au H.C. Wainwright Global Investment Conference le 9 septembre à 13h30 ET. Toutes les présentations seront diffusées en webcast sur le site relations investisseurs d’Alector et les rediffusions seront accessibles pendant 90 jours.
Alector (NASDAQ: ALEC), ein biotechnologisches Unternehmen in der Spätphase, das sich auf Therapien gegen Neurodegeneration spezialisiert hat, gab seine Teilnahme an drei bevorstehenden Gesundheitsinvestoren-Konferenzen im September 2025 bekannt.
Das Unternehmen wird am Cantor Global Healthcare Conference am 4. September um 15:55 Uhr ET, am Morgan Stanley Global Healthcare Conference am 8. September um 10:00 Uhr ET und am H.C. Wainwright Global Investment Conference am 9. September um 13:30 Uhr ET präsentieren. Alle Präsentationen werden per Webcast auf der Investor-Relations-Website von Alector verfügbar sein; Wiederholungen stehen für 90 Tage zur Verfügung.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in the following upcoming investor conferences:
- Cantor Global Healthcare Conference 2025 (New York, New York)
- Thursday, September 4, 2025, at 3:55 p.m. ET, fireside chat
- Morgan Stanley 23rd Annual Global Healthcare Conference (New York, New York)
- Monday, September 8, 2025, at 10:00 a.m. ET, fireside chat
- H.C. Wainwright 27th Annual Global Investment Conference (New York, New York)
- Tuesday, September 9, 2025, at 1:30 p.m. ET, company presentation
A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.
About Alector
Alector is a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. Leveraging the principles of genetics, immunology, and neuroscience, the company is advancing a portfolio of genetically validated programs that aim to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function. Supported by biomarkers, Alector’s product candidates seek to treat a range of indications, such as frontotemporal dementia, Alzheimer’s disease, and Parkinson's disease. The company is also developing Alector Brain Carrier (ABC), a proprietary blood-brain barrier platform, which is being selectively applied to its next-generation product candidates and research pipeline. ABC aims to enhance the delivery of therapeutics, achieve deeper brain penetration and efficacy at lower doses, and ultimately improve patient outcomes while reducing costs. Alector is headquartered in South San Francisco, California. For more information, please visit www.alector.com.
Alector Contacts:
Alector
Katie Hogan
202-549-0557
katie.hogan@alector.com
Argot Partners (media)
David Rosen
646-461-6387
alector@argotpartners.com
Argot Partners (investors)
Laura Perry
212-600-1902
alector@argotpartners.com
FAQ
When is Alector (ALEC) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access Alector's (ALEC) healthcare conference presentations?
Which investor conferences is Alector (ALEC) attending in September 2025?
What type of company is Alector (ALEC)?
